Fundamental knowledge gaps in relation to the 3 epimer of 25-hydroxycholecalciferol [3-epi-25(OH)D 3 ] limit our understanding of its relevance for vitamin D nutrition and health. The aims of this study were to characterize the 3-epi-25(OH)D 3 concentrations in a nationally representative sample of adults and explore its determinants. We also used data from a recent randomized controlled trial This trial was registered at clinicaltrials.gov as NCT01990872.
Introduction
Synthesis in the skin on exposure to UVB sunshine and dietary sources (food and supplements) are the main sources of vitamin D for humans (1) . The metabolic pathway of this endogenously and exogenously derived vitamin D through its various hydroxylation and oxidation events was described comprehensively previously (1) (2) (3) . Recently, it was discovered that vitamin D can alternatively be metabolized through a 3 epimerization pathway that parallels the standard metabolic pathway (4, 5) and thus accounts for the presence of epimerized vitamin D metabolites in human sera.
Although it was suggested that the 3 epimer of 1,25-dihydroxycholecalciferol (1,25-dihydroxyvitamin D 3 ) possesses some but not all of the physiologic functionality of 1,25-dihydroxyvitamin D 3 per se (6) (7) (8) (9) , there is a general consensus that additional priority research is necessary to establish the physiologic function of 3 epimers of vitamin D (5, 10, 11) . Furthermore, whether the 3 epimer of 25-hydroxycholecalciferol [3-epi-25(OH)D 3 ] 6 , which will influence the concentration of the 3 epimer of 1,25-dihydroxyvitamin D 3 , should or should not be included in the serum total 25-hydroxycholecalciferol [25(OH)D 3 ] estimate and the consequences for associated analytics was also discussed (5, (10) (11) (12) . In addition to these key considerations, other fundamental knowledge gaps also pertain to other aspects of 3-epi-25(OH)D 3 , all of which are in need of being addressed to have the fullest understanding of the relevance of this metabolite for vitamin D nutrition and indeed health in early and later life. For example, the percentage detectable 3-epi-25(OH)D 3 in sera from adults was reported variably from 0% to 100%, as recently comprehensively reviewed by Bailey et al. (5) . However, the 9 studies included in that systematic review were of relatively small sample sizes (n = 5-212 and 1 with n = 501), some were in not very well-characterized individuals, and some used a range of different LC-MS/MS methods (5) .
The putative enzyme responsible for the 3 epimerization has yet to be identified (5), leading to calls for clarification on whether the 3-epi-25(OH)D 3 is obtained exogenously (e.g., from food or supplemental sources) or made endogenously (5, 10, 11, 13) . Engelman et al. (14) , in their recent multivariable regression analysis of serum 3-epi-25(OH)D 3 in a population-based sample of 303 adults, showed that being sampled in summer, greater sun exposure, vitamin D supplement use, and the number of alcoholic drinks were all positive determinants.
Thus, the aims of the present work were 1) to characterize the 3-epi-25(OH)D 3 concentrations in participants (aged 18-84 y) of the recent National Adult Nutrition Survey (NANS) in Ireland, 2) to explore its determinants, and 3) to evaluate the impact of its inclusion in serum total 25- 
Participants and Methods
The NANS sample Participant sampling and recruitment procedures and methods of data collection. A detailed description of the methodology used in NANS, including the sampling procedure and sample recruitment, was reported previously (15, 16) . Briefly, the fieldwork phase of NANS was performed between October 2008 and April 2010, providing a seasonal balance to the data and biologic sample collection. To achieve a nationally representative sample of community-dwelling adults aged $18 y, a quota sampling approach was adopted using data from the 2006 Census (17) . A sample of 1500 free-living adults to represent a population of ;4.2 million participated in the dietary survey. There were few exclusion criteria, other than pregnancy/lactation and inability to complete the survey due to disability. The study was approved by the Clinical Research Ethics Committee of the Cork Teaching Hospitals, University College Cork and the Human Ethics Research Committee of University College Dublin. All eligible and willing participants gave their written consent according to the Helsinki Declaration.
Analysis of the demographic features in this sample showed it to be a representative sample of Irish adults with respect to age, sex, social class, and geographical location when compared with census data (15) (16) (17) . Although participation in the survey did not require provision of a blood sample as an eligibility criterion, all participants were asked whether they were willing to provide a blood sample. Of the total group of respondents, 75.5% (n = 1132) provided a blood sample. The demographic features of the group of participants who provided a blood sample and those in the entire sample were described previously (15, 16) . Seasonality was based on the date the respondents provided the blood sample-November to March (representing the ''winter'' period) or April to October (representing the ''summer'' period)-consistent with studies based on NHANES (18) and the recent analysis of Canadian Health Measures Survey for vitamin D status (19) .
The approach to food intake data collection, food quantification, and estimation of vitamin D intake in NANS was provided in detail previously (15, 16) . Of note, food intake data were analyzed using WISP version 3.0 (Tinuviel Software), which uses data from McCance and WiddowsonÕs The Composition of Foods, 5th and 6th editions plus all 9 supplemental volumes, to generate nutrient intake data, as described previously (15, 20) . Information on social class and education level, smoking status, alcohol intake, and medication usage (including those that contained nutrients) was also collected (15, 16) . Anthropometric measures, including height, weight, waist and hip circumference, and measures of body composition, were taken in the respondentÕs homes, as described previously (15) . The approach toward assessment of vitamin D-containing supplement consumption was described previously (15, 16) .
Blood collection. Blood samples were collected by venipuncture into a vacutainer tube by a qualified nurse at designated centers within the survey area or in the respondentÕs home if the respondent could not travel. Bloods were transported to the laboratory for additional processing, and serum was stored at 280°C until required for analysis.
The vitamin D RCT in older adults A 15-wk randomized, placebo-controlled, double-blind vitamin D 3 intervention (20 mg/d) study conducted in the winter in free-living women and men (ratio of ;2.5:1) aged $50 y (n = 125) stratified according to calcium intake (moderate-low: <700 mg/d; or high: >1000 mg/d) was described in detail previously (21) . The baseline characteristics of the older adults who completed the intervention are shown in Supplemental 3 , which was shown to be absent. Repeated-measures ANOVA showed that there was no significant time 3 vitamin D treatment 3 calcium intake grouping interaction effect (P = 0.20 for interaction in both cases) or calcium intake grouping 3 time interaction effects (P > 0.72 for interaction in both cases) on mean serum total 25(OH)D or 3-epi-25(OH)D 3 concentrations over the 15-wk intervention period. Serum total 25(OH)D increased and decreased in the vitamin D 3 and placebo groups, respectively, and of similar magnitudes in those with calcium intakes <700 and >1000 mg/d (21) . Therefore, because of the lack of calcium intake grouping effect, we were able to combine groups and examine the effect of vitamin D 3 supplementation (n = 64) or placebo (n = 61) on serum 3-epi-25(OH)D 3 and 25(OH)D 3 concentrations and their ratio over winter. There was no difference (P > 0.32 in all cases) in the mean age, weight, height, BMI, and the proportion of men-to-women mean habitual dietary calcium or vitamin D at baseline among the placebo and vitamin D 3 -supplemented groups. LC-MS/MS method was described previously (22) . The interassay CV of the method was <5% for all 25(OH)D metabolites, whereas the intra-assay CV was <6%. The following categorical variables were included: 1) vitamin D-containing supplement use (0, no supplements; 1, taking supplements); 2) calcium-containing supplement use (0, no supplements; 1, taking supplements); 3) season (0, winter; 1, spring; 2, autumn; 3, summer); 4) sex (0, female; 1, male); 5) sun habits (0, avoids sunshine; 1, sometimes in the sun; 2, prefers sunshine exposure); 6) frequency of sunscreen use (0, never; 1, rarely; 2, sometimes; 3, always); and 7) smoking status (0, smoker; 1, ex-smoker; 2, non-smoker). The following continuous numerical variables were included: 1) age (years); 2) waist circumference (centimeters); 3) serum creatinine (millimoles per liter); 4) serum 25(OH)D 2 (nanomoles per liter); 5) mean daily intake (MDI) of magnesium (milligrams per day); 6) MDI of calcium (excluding that from supplements; milligrams per day); 7) MDI of vitamin D (excluding that from supplements; micrograms per day); 8) MDI of total ethanol intake (grams per day); and 9) total meat intake (which included fresh, processed, and meat dishes for beef, pork, lamb, and poultry; grams per day). Linear models of the response in a repeated-measures analysis for the differences in serum 25 (Fig. 1) .
Results

Distribution
There was no significant correlation between serum 3-epi-25(OH)D 3 and age (r = 0.005; P > 0.42, n = 1082).
The mean 3-epi-25(OH)D 3 concentration and %3-epi-25(OH)D 3 by quartile of serum 25(OH)D 3 concentration are shown in Table 1 . Although the mean 3-epi-25(OH)D 3 concentration increased linearly by quartile of serum 25(OH)D 3 concentration, the %3-epi-25(OH)D 3 was similar in the lowest 3 quartiles and only significantly (P < 0.05) increased in the highest quartile. Overall, the mean, 10th, 50th (median), and 90th percentiles of %3-epi-25(OH)D 3 were 4.6%, 3.1%, 4.4%, and 6.5%, (Fig. 3) . Mean serum 25(OH)D 3 and 3-epi-25(OH)D 3 concentrations decreased significantly (P < 0.0001) in the placebo group from baseline to midpoint, and, although serum 25(OH)D 3 continued to decline modestly to endpoint (P < 0.001), serum 3-epi-25(OH)D 3 concentrations remained similar (P = 0.16) (Fig. 3) .
There was no significant vitamin D 3 treatment group 3 time interaction effects (P = 0.54) on serum %3-epi-25(OH)D 3 in older adults over 15 wk of winter (data not shown).
Discussion
To our knowledge, the present study is the first description of the distribution of serum 3-epi-25(OH)D 3 in a nationally representative sample of adults. The vast majority of participants (96.4%) had quantifiable (i.e., greater than the LOQ) serum 3-epi-25(OH)D 3 concentrations, which is in line with the findings from some (range, 90-99% detectable) (10, (28) (29) (30) but not all studies in adults (range, 0-80% detectable) (31) (32) (33) (34) (35) The lack of understanding in relation to the source, not to mention the reason for the presence, of the 3-epi-25(OH)D 3 in serum was reported widely (5, 10, 11, 14) . Although a number of reports investigated associations between 3-epi-25(OH)D 3 and individual factors, such as age (10, 30) and season (36), Engelman et al. (14) in their multivariable regression analysis of serum 25(OH)D 3 , 3-epi-25(OH)D 3 , and %3-epi-25(OH)D 3 in a populationbased sample of 303 adults showed that being sampled in summer vs. winter season, more sun exposure, vitamin D intake from supplements, and the number of alcoholic drinks were positive determinants of serum 3-epi-25(OH)D 3 , whereas waist circumference was a significant negative determinant, and age, sex, and vitamin D intake from foods were not associated with the 3 epimer. Their model explained 37% and 26% of variability in serum 25(OH)D 3 and 3-epi-25(OH)D 3 concentrations, respectively (14) . In the present study, in a much larger and nationally representative sample of adults, an expanded list of potential determinants explained a similar extent of the variability in serum 25(OH)D 3 concentrations in the present study. Although serum 3-epi-25(OH)D 3 was not significantly correlated with age in the present study in agreement with the lack of association with age in studies by Engelman et al. (14) and Lensmeyer et al. (10) , being aged 50-64 and $65 y was a significant positive predictor of serum 3-epi-25(OH)D 3 concentration. This may relate to the higher intake of vitamin D from supplements in older participants in our survey (16) , which will increase the serum 25(OH)D 3 concentration. Interestingly, the factors included in our regression model only explained 15% of the variability in %3-epi-25(OH)D 3 , in close agreement with the findings by Engelman et al. (14) . Availability of UVB sunshine, in the context of sampling season and sun preference, was the strongest positive determinant, whereas dietary vitamin D intake (but not supplement use) was only a borderline significant positive determinant of %3-epi-25(OH)D 3 .
Although the associations reported in the present study and those by Engelman et al. (10) provide some biologic plausibility and insight into the possible role of factors that increase and decrease serum 25(OH)D 3 in determining serum 3-epi-25(OH)D 3 concentrations, they do not provide evidence of causal relations. In this regard, the present data on the response of serum 3-epi-25(OH)D 3 concentrations to vitamin D 3 supplementation over winter in our RCT in older adults is the first, to our knowledge, to show that, during winter, the concentration of the epimer decreases (as shown in the placebo group) unless additional vitamin D 3 is supplied (as shown in the vitamin D 3 -supplemented group), in which case it increases significantly. These changes closely mirrored the changes in serum 25(OH)D 3 concentrations, and the ratio of 3-epi-25(OH)D 3 to 25(OH)D 3 was constant.
The quality control measures used in the present study demonstrate that the epimer was not an artifact of the extraction or LC-MS/MS procedures. We acknowledge the possibility that what we are identifying as 3-epi-25(OH)D 3 could plausibly be 25-hydroxyprevitamin D 3 . However, as suggested recently by Lensmeyer et al. (10) , we also believe this unlikely given that the peak we label as 3-epi-25(OH)D 3 is identical to what the National Institute of Science and Technology has identified as 3-epi-25(OH)D 3 based on the ability of our LC-MS/MS method to recover the values of 3-epi-25(OH)D 3 in the human serum reference material. This is also the case for our analysis of the sera used in the CDC Vitamin D Standardization Certification Program (23) .
In conclusion, to our knowledge, we provide for the first time data on serum 3-epi-25(OH)D 3 in a nationally representative sample of adults. Furthermore, combining the observational and RCT data from the present study seems to suggest that both dietary supply and dermal synthesis of vitamin D 3 contribute to the concentration of 3-epi-25(OH)D 3 in serum. This in turn suggests, at least in part, the involvement of a 3-epimerase enzyme, although this has not yet been isolated. However, the data do not discount the possibility of an additional direct dietary route of exposure to 3-epi-25(OH)D 3 per se, as might occur with consumption of foods of animal origin, in particular meat and eggs that contain vitamin D 3 but also 25(OH)D 3 (40) , and therefore the possibility of 3-epi-25(OH)D 3 , although this has yet to be reported. Meat intake was a significant determinant of serum 3-epi-25(OH)D 3 but not 25(OH)D 3 in the present regression analysis. Clearly, more research in terms of the functionality and sources of 3-epi-25(OH)D 3 is warranted.
